CoChat

Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes

Toft-Nielsen, M.-B., Madsbad, S., Holst, J. J. · 2001 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

GLP-1 lowers blood glucose in fasting type 2 diabetic patients. To clarify the relation of the effect of GLP-1 to obesity, blood glucose, beta-cell function, and insulin sensitivity, GLP-1 (1.2 pmol/kg.min) was infused iv for 4-6 h into 50 fasting type 2 diabetic patients with a wide range of age, body mass index, HbA1c, and fasting plasma glucose. The effectiveness of GLP-1 was evaluated by calculation of a glucose disappearance constant for each individual (Kg, linear slope of log-transformed plasma glucose), and by the lowest stable glucose level (Nadir plasma glucose) obtained during the infusion. Grouped according to fasting plasma glucose (<10, 10-15, >15 mmol/liter), Kg values were 0.45 +/- 0.03, 0.38 +/- 0.04, and 0.28 +/- 0.04%/min (P = 0.005), and Nadir plasma glucose values were 4.7 +/- 0.1 (3.9-5.9), 5.8 +/- 0.4 (4.3-8.4), and 8.7 +/- 1.4 (6.2-18.7) mmol/liter (P = 0.0003). Nonresponders were not identified. Multiple regression analysis with Kg or Nadir plasma glucose as the dependent parameter and body mass index, age, gender, diabetes duration, and significantly correlated parameters (in multiple regression for Kg: fasting plasma glucose, fasting nonesterified fatty acid, dipeptidyl peptidase activity, peak insulin, and the logarithm of beta-cell function; and for Nadir plasma glucose: fasting plasma glucose, fasting nonesterified fatty acid, dipeptidyl peptidase activity, delta glucagon decrement, F-GLP-1 total, logarithm of beta-cell function, and Kg) as independent parameters resulted in fasting plasma glucose as the only significant predictor of Kg, and fasting plasma glucose and Kg as predictors of Nadir plasma glucose. Kg and Nadir plasma glucose were neither influenced by treatment nor by neuropathy per se. In conclusion, GLP-1 lowers plasma glucose in type 2 diabetes regardless of severity, but glucose elimination is faster and obtained glycemic level lower in patients with the lower fasting plasma glucose. Not all patients can be expected to reach normoglycemia.

Overview

Integrity signals

Registry

Crossref · 10.1210/jcem.86.8.7743

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 173

Metadata

Authors
Toft-Nielsen, M.-B., Madsbad, S., & Holst, J. J.
Affiliations
University of Copenhagen (DK)
Corresponding author
Holst, J. J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2001-08
Volume
86
Issue
8
Pages
3853-3860
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2056934377
Cited by
164
References
24
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 8 · 2015: 9 · 2014: 14 · 2013: 16 · 2012: 9
FWCI
3.45
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
Hvidovre Hospital
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, type 2 diabetes, fasting blood glucose, glucose disappearance rate, beta-cell function, insulin sensitivity, glucagon, obesity, neuropathy
MeSH terms
Autoantibodies, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Fasting, Fatty Acids, Nonesterified, Female, Glucagon, Glutamate Decarboxylase, Glycated Hemoglobin, Humans, Infusions, Intravenous, Insulin, Islets of Langerhans, Isoenzymes, Male, Middle Aged, Peptide Fragments, Protein Precursors, Regression Analysis, Body Mass Index, Dipeptidyl Peptidase 4, Area Under Curve, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes. https://app.cochat.ai/papers/10.1210/jcem.86.8.7743
The paper
Toft-Nielsen, M.-B., Madsbad, S., & Holst, J. J. (2001). Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.8.7743

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.